Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
REVENUE
OPERATING EXPENSES
General and administrative	6,016,056	9,085,100
Research and development	3,281,945	3,354,923
Gain on waiver of common stock issuable	(1,542,000)
Total operating expenses	7,756,001	12,440,023
LOSS FROM OPERATIONS	(7,756,001)	(12,440,023)
OTHER INCOME
Interest income	77,688
Total other income	77,688
NET LOSS	$ (7,678,313)	$ (12,440,023)
Net loss per common share - basic and diluted	$ (0.75)	$ (1.43)
Weighted average number of common shares outstanding - basic and diluted	10,272,641	8,676,701
COMPREHENSIVE LOSS
Net loss	$ (7,678,313)	$ (12,440,023)
Other comprehensive loss - loss on foreign currency translation	(15,044)	(25,513)
Total comprehensive loss	$ (7,693,357)	$ (12,465,536)